Megan F Saalfrank1, Junling Wang, Lawrence M Brown. 1. Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, 847 Monroe Avenue, Room 205, Memphis, TN 38163, USA. msaalfra@utmem.edu.
Abstract
AIMS: Cost-utility analysis is an economic evaluation technique that takes into consideration individual preferences for health outcomes. It is crucial to determine whether racial and ethnic groups differ in preferences for health states because then we need to determine which group's utility score should be used to conduct a cost-utility analysis that yields equitable results to all members of society. METHODS: A PubMed search was conducted to identify the relevant studies. RESULTS: There exists a potential to either undervalue or overvalue health states along racial and ethnic lines when population-based utility scores are used for clinical or policy decision-making. Some argue that if systematic racial and ethnic differences exist, then race/ethnicity-specific measures should be incorporated in the economic evaluations, at least for interventions targeted at the prevention and treatment of diseases which disproportionately affect minorities. Yet, others believe that there are troubling social and ethical implications to using subgroup health preferences as they also have the potential to disadvantage minorities. CONCLUSIONS: Attention is required for the equity issues related to the utilizations of cost-utility analysis.
AIMS: Cost-utility analysis is an economic evaluation technique that takes into consideration individual preferences for health outcomes. It is crucial to determine whether racial and ethnic groups differ in preferences for health states because then we need to determine which group's utility score should be used to conduct a cost-utility analysis that yields equitable results to all members of society. METHODS: A PubMed search was conducted to identify the relevant studies. RESULTS: There exists a potential to either undervalue or overvalue health states along racial and ethnic lines when population-based utility scores are used for clinical or policy decision-making. Some argue that if systematic racial and ethnic differences exist, then race/ethnicity-specific measures should be incorporated in the economic evaluations, at least for interventions targeted at the prevention and treatment of diseases which disproportionately affect minorities. Yet, others believe that there are troubling social and ethical implications to using subgroup health preferences as they also have the potential to disadvantage minorities. CONCLUSIONS: Attention is required for the equity issues related to the utilizations of cost-utility analysis.
Authors: Norah E Mulvaney-Day; Marcela Horvitz-Lennon; Chih-Nan Chen; Mara Laderman; Margarita Alegría Journal: Qual Life Res Date: 2010-08-01 Impact factor: 4.147